For levothyroxine, which is highly dependent on consistent absorption to maintain stable blood levels, a slower gastric transit time can mean more exposure to the absorptive surfaces of the gastrointestinal tract
It has a fuller preclinical record plus clinical trial data tied to its approved indication [2, 3, 4]
theoretical concerns include IGF-1 pathway effects, PEG immune reactions, injection-site risks, product-quality problems, and unknown long-term safety 15 16 20
About half ( 54% ) of Americans who have used GLP-1 medications, including those with health insurance, say they had difficulty affording them
This results in increased plasma GH levels, which would affect many biological processes
It's about understanding pathways, mechanisms of action, and how different compounds can complement each other to create a powerful, targeted effect